SNYR vs PRGO vs PBH vs CLAR

For growth investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger pick with 1. 1% revenue growth year-over-year, versus -18. 6% for Synergy CHC Corp. (SNYR). Synergy CHC Corp. (SNYR) offers the better valuation at 1. 4x trailing P/E, making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Synergy CHC Corp.

(SNYR) is the cheapest at 1. 4x versus Prestige Consumer Healthcare Inc. at 12. 7x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +18. 4%, compared to -82. 8% for Clarus Corporation (CLAR). Over 10 years, the gap is even starker: PBH returned -3. 7% versus SNYR's -94. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Prestige Consumer Healthcare Inc.

(PBH) is the lower-risk stock at 0. 53β versus Clarus Corporation's 1. 34β — meaning CLAR is approximately 151% more volatile than PBH relative to the S&P 500. On balance sheet safety, Clarus Corporation (CLAR) carries a lower debt/equity ratio of 6% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Prestige Consumer Healthcare Inc.

(PBH) is pulling ahead at 1. 1% versus -18. 6% for Synergy CHC Corp. (SNYR). On earnings-per-share growth, the picture is similar: Synergy CHC Corp. grew EPS 297. 2% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PBH leads at 1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus -8. 2% for CLAR. At the gross margin level — before operating expenses — SNYR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 12. 0x for Prestige Consumer Healthcare Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLAR: 73. 0% to $5. 00.

In this comparison, PRGO (9.

8% yield), CLAR (3. 5% yield) pay a dividend. SNYR, PBH do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Prestige Consumer Healthcare Inc.

(PBH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53)). Both have compounded well over 10 years (PBH: -3. 7%, SNYR: -94. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SNYR (Healthcare) and PRGO (Healthcare) and PBH (Healthcare) and CLAR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SNYR is a small-cap deep-value stock; PRGO is a small-cap income-oriented stock; PBH is a small-cap deep-value stock; CLAR is a small-cap income-oriented stock. PRGO, CLAR pay a dividend while SNYR, PBH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.